BRAF and plasma cell myeloma: Taken together, genes involved in mitogen-activated protein kinase (MAPK) pathway such as NRAS, KRAS, and BRAF (RAS pathway 43%) and those in the nuclear factor (NF)-kappa B pathway (17%) are recurrently mutated in myeloma and these are likely important drivers of myelomagenesis [55].